|
Management of Carbapenem-resistant Enterobacteriaceae (CRE)
Public Health Ontario, the Ministry of Health and Long-Term Care, Quality Management Program Laboratory Services (QMP-LS) and health care providers are working together to understand and manage the incidence of Carbapenem-resistant Enterobacteriaceae (CRE). This includes appropriate guidance for effective infection prevention and control (IPC) management practices, surveillance programs and guidance on laboratory processing, screening and reporting.
- PHO Laboratory Recommendations for the Identification of CRE
- Provincial Infectious Diseases Advisory Committee IPC best practice document: Routine Practices and Additional Precautions: Annex A (Screening Testing and Surveillance for AROs in All Health Care Settings)
- PHO Carbapenem-Producing Enterobacteriaceae (CPE) Surveillance Form
- CRE letter from the Ontario Chief Medical Officer of Health, December 2011
- Dec 12, 2011 PHO Webinar Presentation
|